Global Diabetic Macular Edema Market Size By Product (Intravitreal Injections, Intravitreal Implants), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies), By Geographic Scope And Forecast

Diabetic Macular Edema Market Size And Forecast

Diabetic Macular Edema Market size was valued at USD 10.72 Billion in 2024 and is projected to reach USD 14.74 Billion by 2031, growing at a CAGR of 4.48% from 2024 to 2031.

The increasing population suffering from diabetes, causing diabetic macular edema in the patients, will help drive the growth of the Diabetic Macular Edema Market. The Global Diabetic Macular Edema Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Diabetic Macular Edema Market Definition

So, diabetic macular edema? It's basically a complication of type 1 or type 2 diabetes where extra fluid starts messing with the macula in your eye, causing vision problems. You see, the macula is super important for focusing and seeing those fine details – it’s located in the center of your retina, that lining at the back of your eye packed with blood vessels. What happens is, high blood sugar levels from diabetes can damage those blood vessels, leading to them leaking fluid and causing swelling. This damage is called retinopathy. The good news is there are treatment options for diabetic macular edema, and the earlier it's caught and monitored by an eye care doctor, the easier it is to manage!

Increasing blood sugar levels damage the small blood vessels in the eyes. High cholesterol levels also damage the blood vessels, which causes an increased risk for diabetic macular edema. Operating with your healthcare team to keep your blood sugar levels as near to target as possible is a vital part of keeping your eyes healthy. In cases of diabetes, pregnancy increases the risk of producing diabetic macular edema. The doctor may advise for frequent eye checkups during pregnancy.

Global Diabetic Macular Edema Market Overview

The global market for treating Diabetic Macular Edema is booming, and here's whymore and more people are experiencing eye problems like various types of macular edema. Diabetes is on the rise, which unfortunately means more cases of diabetic macular edema too. Plus, there's lots of exciting research and development happening to find better treatments. We're also seeing a bigger emphasis on preventative care, like regular eye exams, and people are just generally more aware of the importance of eye health. All these things are fueling the growth of this market! The Centres for Disease Control and Prevention reported that in 2018, around 34.2 million Americans had diabetes. Sadly, many are developing type 1 and type 2 diabetes at younger ages, and some ethnic groups are seeing even higher rates of type 2 diabetes.

Controlling diabetes is made a health priority in developed countries like the U.S. The lack of attention is given to diabetic macular edema management and more focus on other diabetes complications. The anti-VEGF and corticosteroid therapies have changed diabetic macular edema. Still, there is a gap in clinical information among clinicians that hamper the market growth of the market. Whereas, improvement in ophthalmic surgery techniques and investment in research and development by various pharmaceutical companies are opportunities for the growth of the market.

Global Diabetic Macular Edema MarketSegmentation Analysis

The Global Diabetic Macular Edema Market is Segmented on the basis of Product, Distribution Channel, and Geography.

Diabetic Macular Edema Market, By Product

• Intravitreal Injections
• Intravitreal Implants

Based on Product, the market is segmented into Intravitreal Injections and Intravitreal Implants. The Intravitreal Injection segment holds a large number of shares in the market because it helps treat many retinal conditions, and diabetic retinopathy and retinal vein occlusion are the most common conditions treated with intravitreal anti-VEGF drugs due to its being easily available and cost-effective than Intravitreal Implants.

Diabetic Macular Edema Market, By Distribution Channel

• Retail Pharmacies
• Hospital Pharmacies

Based on Distribution Channel, the market is segmented into Retail Pharmacies and Hospital Pharmacies. The Hospital Pharmacies segment holds a large number of shares in the market because most of the countries globally use hospital pharmacies to deliver intravitreal injections and implants to outpatients, increasing the market growth of diabetic macular edema.

Diabetic Macular Edema Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

On the basis of Geography, the Global Diabetic Macular Edema Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The North American region holds a large number of shares in the market because of an increasing number of patients suffering from type-2 diabetes and the presence of top-tier photocoagulation lasers. The Asia-Pacific is the fastest-growing region in the market because of increasing incidence, awareness of ophthalmic disorders, and access to advanced technologies the factor for the growth of diabetic macular edema globally.

Key Players

The “Global Diabetic Macular Edema Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Pfizer Inc., Allergan PLC, Novartis AG, Clearside Biomedical Inc, Ariam Pharmaceuticals, Valeant Pharmaceuticals, Regenron PLC, Bayer AG, pSivida Corporation, Alimera Sciences Inc. The competitive landscape section also includes key development strategies, Market share, and Market ranking analysis of the above-mentioned players globally.

Key Developments

• On December 2018, Clearside Biomedical submitted a new medication, XIPERE, to treat macular edema associated with Uveitis.
• On May 2021, Faricimab (Roche), KSI 301 (Kodiak Sciences Inc.), and Beovu (Novartis) late-stage products have shown promising results in diabetic macular edema and are expected to improve the dosing interval.

Report Scope

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

We dig deep, looking at the market from all angles – both the dollars and cents, and the stuff that's harder to measure. We'll give you the market value (in USD Billion) for every slice and dice of the market. You'll see which regions and segments are poised for the biggest boom and who's likely to be king of the hill. We break down the market geographically, showing you where the action is and what's driving it. Plus, we size up the competition, ranking the big players and highlighting their latest moves (new stuff, deals, expansions, and takeovers) from the last five years. You'll get detailed profiles of these companies, including their background, key insights, product comparisons, and a good old SWOT analysis. We'll also give you our take on the current and future of the market, pointing out where the growth is, what's fueling it, and what's holding it back, in both up-and-coming and established areas. We dive into the market's inner workings using Porter's five forces and map out the whole Value Chain. Finally, we paint a picture of the market's dynamics, spotlighting the growth opportunities that lie ahead and we also include 6 months of post-sales analyst support.

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.